RRX Q1 2026 Earnings EPS Surpasses Estimates Shares Edge Higher Day One Biopharmaceuticals DAWN Q4 2025 Earnings EPS Miss Reflects RD Spend Amid PreRevenue Status MDLN Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response Contineum Therapeutics Inc CTNM Q1 2026 Earnings Narrower Loss Beats Expectations ProQR Therapeutics Q1 2026 Earnings Narrower Net Loss No Revenue as Pipeline Progress Drives Stock Gains Indaptus Therapeutics Q4 2025 Earnings EPS Misses Estimates on Minimal Revenue Stock Surges